Compare Humana Inc (HUM) vs Twilio Inc (TWLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Twilio Inc — how do they compare? Humana Inc trades at $407.19 (market cap $47.81B), while Twilio Inc trades at $195.29 (market cap $31.15B). The key difference: Humana Inc is the larger of the two by market cap, and Humana Inc pays a 0.89% dividend while Twilio Inc pays none. Which is the better fit depends on your goals.
| HUM | TWLO | |
|---|---|---|
Market Cap | $47.81B | $31.15B |
Sector | Health | Technology |
52-Week High | $409.42 | $236.64 |
52-Week Low | $163.67 | $92.44 |
Enterprise Value | $56.85B | $29.87B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
Twilio (TWLO) trades at $208.56, up 0.86% with a bullish technical outlook. The stock has beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected on August 6, 2026. Revenue grew to $5.07B in 2025, and net income turned positive at $33.83M. Analyst sentiment is strongly positive with a consensus price target of $223.00. Operating cash flow improved significantly to $1.00B in 2025, indicating strengthening financial health.
The outlook for Twilio is optimistic due to consistent earnings beats and robust revenue growth, though high valuation multiples pose risks. Key opportunities include AI-driven communication tools and margin expansion under new leadership. Risks include intense competition and execution challenges in sustaining profitability. Investors should monitor Q2 2026 earnings for continued momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Twilio Inc
Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
Read more on TWLO →
